Towards Digital Management of Paediatric Asthma
Towards Digital Management of Pediatric Asthma:a Pilot Study
Assistance Publique - Hôpitaux de Paris
50 participants
Nov 25, 2025
INTERVENTIONAL
Conditions
Summary
This pilot study aims to explore whether a digital approach to managing childhood asthma using connected inhalers and video consultations triggered by alerts from these devices - could work as well as standard in-person care. The connected inhalers track when children use their daily prevention medication and their rescue medication for asthma symptoms. If a child misses several days of prevention medication or uses their rescue inhaler frequently, their doctor receives an alert and can schedule a video consultation to adjust their treatment. Fifty children aged 4-12 years with asthma will participate for 8 months, with half using this digital system and half receiving usual care. The study will measure whether this new approach is practical and acceptable to families and doctors, and will look at its effects on asthma control, quality of life, and healthcare use. The results will help design a larger study to fully test if this digital approach could improve asthma care for children.
Eligibility
Inclusion Criteria12
- Aged 4 to 12, whose asthma has been diagnosed by a physician
- Followed up for their asthma by a pediatrician or pediatric pulmonologist
- With asthma severity corresponding to GINA grades 2, 3 or 4 (Global Asthma Initiative Guidelines)
- Whose controller and reliever treatments are administered using pressurized metered-dose inhalers (p-MDIs)
- With social security
- Whose parents or legal guardian(s):
- Have given their written and informed consent for their child's participation and their participation,
- Have a smartphone in the household that can download the application and is compatible with it,
- Are capable, in the opinion of the investigator, of understanding the use of the mobile application and module FRENCH CARE specifically dedicated to the research and the digital inhalers provided.
- Patients with another pathology that could interfere with the evaluation of the endpoints (e.g, bronchopulmonary dysplasia, cystic fibrosis, etc.)
- Patients whose parents or legal representative(s) are, in the opinion of the investigator, unable to understand the purpose of the study and/or express their consent.
- Patients benefiting from State Medical Aid
Exclusion Criteria1
- \- Patient who did not use the system within 15 days of the inclusion visit
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Telemonitoring system relying on the use of 2 digital inhalers FindAir ONE for pMDI, one for the controller the other for the reliever treatment. Active telemonitoring using real-time data from digital inhalers. Investigators will be alerted by email if a child: 1. fails to take his or her controller treatment for 4 continuous days and/or 2. uses \> 4 doses of reliever treatment over 24 hours 3. uses \< 12 doses of reliever treatment over 3 months (indication to decrease the controller treatment) In these cases, investigators will be asked to schedule a teleconsultation within 2 working days with the family and to adapt treatments as needed. They may ask the family to use the portable spirometer and oximeter if necessary. No systematic consultation will be planned.
Standardized care + passive recording of asthma treatment use (controller and reliever treatments) using digital inhalers
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06902766